{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:09:00Z","timestamp":1777554540983,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methyldibromoglutaronitrile\/phenoxyethanol (MDBGN\/PE) is a broad-spectrum preservative mixture used in consumer and industrial products.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aims of the study were (1) to characterize the prevalence and clinical relevance of patch test reactions to MDBGN\/PE and the epidemiology of positive patients and (2) to determine the frequency of concomitant reactions of MDBGN\/PE and its components.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used a retrospective analysis of cross-sectional data compiled by the North American Contact Dermatitis Group from 1994 to 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 55,477 tested patients, 2674 (4.8%) had positive patch test reactions to MDBGN\/PE (1.0%\u20132.5% petrolatum [pet]); most were + (63.3%) or ++ (22.3%). Clinical relevance was considered definite in 3.0% and probable in 19.3% of reactions. Common dermatitis sites included the hands (26.4%), scattered\/generalized distribution (24.7%), and the face (18.3%). Patients with a positive reaction to MDBGN\/PE and\/or MDBGN and\/or PE were significantly more likely to be male and older than 40 years and\/or had hand dermatitis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.0033). Positivity to MDBGN\/PE 2.0% pet decreased significantly over time (from 6.0% in 1998\u20132000 to 2.5% in 2017\u20132018,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). Personal care products were the most common exposure source (53.2%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over time, positivity to MDBGN\/PE 2.0% pet decreased significantly from 6.0% (in 1998\u20132000) to 2.5% (in 2017\u20132018). The high proportion of weak (63.3%) reactions underscore the need for careful interpretation of patch test sites. Important demographic associations included male sex and age older than 40 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/der.0000000000000732","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T12:00:13Z","timestamp":1615032013000},"page":"256-266","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Patch Testing to Methyldibromoglutaronitrile\/Phenoxyethanol: North American Contact Dermatitis Group Experience, 1994\u20132018"],"prefix":"10.1177","volume":"32","author":[{"given":"Erin M.","family":"Warshaw","sequence":"first","affiliation":[{"name":"From the, *Department of Dermatology, Park Nicollet Health Services, Minneapolis"},{"name":"Department of Dermatology, University of Minnesota, Minneapolis"},{"name":"Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Buonomo","sequence":"additional","affiliation":[{"name":"From the, *Department of Dermatology, Park Nicollet Health Services, Minneapolis"},{"name":"Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis"},{"name":"University of Minnesota Medical School, Minneapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel G.","family":"DeKoven","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald V.","family":"Belsito","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Irving Medical School, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard I.","family":"Maibach","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Zug","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margo J.","family":"Reeder","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber R.","family":"Atwater","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University Medical Center, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Sasseville","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Montreal General Hospital, McGill University, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":", Jr","given":"Joseph F.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Louisville, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie D.","family":"Pratt","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"DeLeo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony F.","family":"Fransway","sequence":"additional","affiliation":[{"name":"Associates in Dermatology, Fort Myers, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90730-6"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2011.10081"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1988.tb05487.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000076799"},{"key":"e_1_3_1_6_2","unstructured":"Opinion of the Scientific Committee on Consumer Products (SCCP): methyldibromoglutaronitrile (sensitisation only). SCCP\/0863\/05. Adopted by SCCP during 3rd plenary meeting; 2005. Available at: https:\/\/ec.europa.eu\/health\/ph_risk\/committees\/04_sccp\/docs\/sccp_o_00f.pdf. Accessed November18 2020."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/10915819609043793"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1989.tb03180.x"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02126.x"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460404.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01572.x"},{"issue":"6","key":"e_1_3_1_12_2","first-page":"1316","article-title":"Contact allergy to preservatives","volume":"164","author":"Schnuch A","year":"2011","unstructured":"Schnuch A, , Lessmann H, , Geier J, et al. Contact allergy to preservatives. Analysis of IVDK data 1996\u20132009. Br J Dermatol, 2011; 164(6):1316\u20131325.","journal-title":"Analysis of IVDK data 1996\u20132009. Br J Dermatol"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.09.047"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000031"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12186"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14063"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14423"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000411"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-019-04517-x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000417"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2010.10060"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00406.x"},{"issue":"4","key":"e_1_3_1_23_2","first-page":"573","article-title":"Significance-prevalence index number: a reinterpretation and enhancement of data from the North American Contact Dermatitis Group","volume":"41","author":"Maouad M","year":"1999","unstructured":"Maouad M, , Fleischer ABJr, ., Sherertz EF, et al. Significance-prevalence index number: a reinterpretation and enhancement of data from the North American Contact Dermatitis Group. J Am Acad Dermatol, 1999; 41(4):573\u2013576.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb00544.x"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70589-4"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00480.x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2008.01364.x"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000296"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01668.x"},{"key":"e_1_3_1_30_2","first-page":"151","article-title":"Contact allergy to Euxyl K 400","volume":"39","author":"Fuchs T","year":"1991","unstructured":"Fuchs T, , Enders F, , Przybilla B, et al. Contact allergy to Euxyl K 400. Dermatosen, 1991; 39:151\u2013153.","journal-title":"Dermatosen"},{"issue":"15","key":"e_1_3_1_31_2","first-page":"73","article-title":"Contact dermatitis to methyldibromoglutaronitrile: emergence of sensitization in the central region of Tunisia","volume":"13","author":"Maoua M","year":"2018","unstructured":"Maoua M, , Aroui H, , Kacem I, et al. Contact dermatitis to methyldibromoglutaronitrile: emergence of sensitization in the central region of Tunisia. Euro Mediterr Biomed J, 2018; 13(15):73\u201377.","journal-title":"Euro Mediterr Biomed J"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12735"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12333"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.04.016"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2003.00033.x"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1992.tb05267.x"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00481.x"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2007.06042"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00529.x"},{"key":"e_1_3_1_40_2","first-page":"e242","article-title":"Clinicians vs","volume":"33","author":"Schnuch A","year":"2019","unstructured":"Schnuch A, , Schubert S, , Geier J. Clinicians vs. epidemiologists: patch testing with methyldibromo glutaronitrile as a controversial issue. J Eur Acad Dermatol Venereol, 2019; 33:e242\u2013e244.","journal-title":"epidemiologists: patch testing with methyldibromo glutaronitrile as a controversial issue. J Eur Acad Dermatol Venereol"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/1091581817716647"},{"key":"e_1_3_1_42_2","unstructured":"US National Institutes of Health Consumer Product Information Database [online database]. Available at: https:\/\/www.whatsinproducts.com\/chemicals\/view\/1\/963\/035691-65-7. Accessed November18 2020."},{"key":"e_1_3_1_43_2","unstructured":"EWG's Skin Deep\u00ae database [online database]. Available at: http:\/\/www.ewg.org\/skindeep. Accessed October18 2020."}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000732","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:50Z","timestamp":1777399550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8,1]]}},"alternative-id":["10.1097\/DER.0000000000000732"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000732","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}